Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com previous post Multiple New Multi-Commodity Targets next post Excellent Gold Intersections Verified at Kiimala Project You may also like Drill Contract Awarded for Elizabeth Hill. Technical Visit... May 9, 2025 Navigating Uncertainty: How Trump’s Tariffs Are Affecting the... August 28, 2025 UPS Batteries For Explosive (EX & ATEX) Environments October 3, 2025 Athena Gold Upsizes Flow-Through Private Placement, Announces Concurrent... April 22, 2025 SPUT’s US$200 Million Uranium Buying Plan Spurs Market... June 18, 2025 3 Best-performing Canadian Cleantech Stocks of 2025 July 18, 2025 Hydrogen Stocks: 9 Biggest Companies in 2025 September 11, 2025 Tech 5: OpenAI Restructures, Apple Pursues AI Search,... May 11, 2025 Basin Energy September 1, 2025 Locksley Advances Multiple Antimony & REE Workstreams October 3, 2025